The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
March 18th 2024
In an announcement by Aquestive Therapeutics, these new findings demonstrated the potential of this orally-administered epinephrine treatment.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Community Practice Connections™: Navigating a New Era of Food Allergy Management
View More
Researchers Look at Dust Mites and Potential Links to Allergies and Asthma
The number of patients dealing with health issues related to asthma and allergies continues to grow and researchers are looking to answer the question of why this is happening. The answer may be at the cellular level and be influenced by a person's environment, including the common dust mite.
Feeding Babies Gluten May Increase Risks for Celiac Disease
The risk of developing celiac disease might be increased in at-risk infants if they are fed gluten, according to findings from a study conducted in Sweden published in Clinical Gastroenterology and Hepatology.
New Indications for Psoriasis Drug Cosentyx Receive FDA Nod
Biologic drug secukinumab (Cosentyx/Novartis), already FDA approved in January 2015 to treat chronic plaque psoriasis, has now been approved for two new indications: the treatment of active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
For patients with seasonal allergies the prescription medications available may not be enough to help with their symptoms and shots may not be an option they want to consider. Newly developed sublingual immunotherapies have been developed to help these patients manage their daily lives.
Q&A With Bryan Martin From The Ohio State University: ACAAI Aims To Move Field Into The Future
The world of medicine is changing and because of that organizations need to change as well. The American College of Allergy, Asthma, & Immunology is no exception to that trend.
For patients with severe seasonal allergies the regularly available medications may not be enough to help their symptoms while the prospect of shots may be prohibitive enough to keep them from getting shots. A newly approved treatment could provide an alternative to the needle.
Why Are Seasonal Allergy Sufferers Using Over-the-Counter Medication if They Want Prescription Meds?
November 5th 2015Pharmacy shelves are lined with different brands to treat seasonal allergies, and most of the time, patients will pick one up. But as a new study found, allergy sufferers actually want prescription medication.